The Reduced Insulinotropic Effect of a Continuous Infusion Relative to a Bolus Injection of GIP

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

December 31, 2008

Conditions
Type 2 Diabetes
Interventions
DRUG

GIP Bolus

bolus injections of synthetic human GIP (50 pmol/kg body weight) administered 30 and 120 min after commencing the hyperglycemic clamp

DRUG

GIP Clamp

hyperglycemic clamp with the continuous intravenous infusion of 2 pmol.kg-1.min-1 synthetic human GIP between 30 and 180 min

PROCEDURE

Oral glucose tolerance test (OGTT)

an oral glucose challenge (75 g)

PROCEDURE

hyperglycemic clamp

a hyperglycemic clamp (capillary venous glucose concentration \~ 8.5 mmol/l)

All Listed Sponsors
lead

Diabeteszentrum Bad Lauterberg im Harz

OTHER

NCT02673554 - The Reduced Insulinotropic Effect of a Continuous Infusion Relative to a Bolus Injection of GIP | Biotech Hunter | Biotech Hunter